In 2010, Wang et al. (178) also took a multi-scale agent-based modeling approach to identify therapeutic targets in concurrent EGFR-TGFβ signaling pathway in non-small cell lung cancer (NSCLC). This evidence concerns the gene TGFB1 and non-small cell lung carcinoma.